Glucose Control and Cardiovascular Outcomes in Clinical Trials of Sodium Glucose Co-transporter 2 Inhibitor Treatments in Type 2 Diabetes
European Endocrinology, 2014;10(2):117–23
A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes
European Endocrinology, 2014;10(1):23–30
Prof Schlumberger talks to ecancertv at ASCO 2014 about the results of the phase three SELECT trial, which was a multicentre, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients...
Dr. Apovian talks about a new number of medications coming to market and how a new guideline might be needed within the next year or two.